Navigation Links
Researchers and company from Luxembourg awarded a grant from Michael J. Fox Foundation
Date:12/14/2012

The Michael J. Fox Foundation grant will be used to study the "Modulation of the CD40/CD40-Ligand neuroinflammatory pathway in Parkinson's preclinical models."

This project could open a new avenue for therapeutic interventions in Parkinson's disease, where current approaches are limited mainly to dopaminergic replacement therapies. Dr. Djalil Coowar, AxoGlia's CSO and Principal Investigator, and his colleague at LSCB, Dr. Manuel Buttini, expect that by blocking neuroinflammation through the disruption of the CD40-CD40L pathway, a neuroprotective, disease-modifying effect will be achieved.

"Modulating neuroinflammation in Parkinson's disease could prove to be of therapeutic benefit and we are grateful to The Michael J. Fox Foundation for their support to our innovative strategies that identify neurorestorative and neuroprotective drug candidates," said AxoGlia's CEO Jean-Paul Scheuren.


'/>"/>

Contact: Jean-Paul Scheuren
info@axoglia.com
352-466-644-6445
University of Luxembourg
Source:Eurekalert

Page: 1

Related biology news :

1. Researchers find new culprit in castration-resistant prostate cancer
2. ASU researchers propose new way to look at the dawn of life
3. New geometries: Researchers create new shapes of artificial microcompartments
4. UGA researchers find algal ancestor is key to how deadly pathogens proliferate
5. Researchers identify new components of the epigenetic code for honey bee development
6. Researchers find new genetic pathway behind neurodevelopmental disorders
7. Researchers investigate impacts of climate change on rare tropical plants
8. Researchers identify proteins that indicate which kidney tumors are most likely to spread
9. Microchoreography: Researchers use synthetic molecule to guide cellular dance
10. Einstein researchers receive 2 Grand Challenges Explorations grants to combat HIV and TB
11. University of Tennessee researchers find fungus has cancer-fighting power
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... RYE, N.Y. , May 11, 2015 ... company, announced the start of a new Phase III ... effect of its novel formulation, CM-AT, on all children ... results of its FDA Phase III double blinded clinical ... who had low levels of the digestive enzyme chymotrypsin. ...
(Date:5/6/2015)... May 6, 2015 LifeBEAM, a developer of ... producer, announced today that they will expand their partnership ... first bio-sensing cycling helmet and the first joint project ... new colors in order to give cyclists more style ... addition, LifeBEAM and Lazer announced their plan to release ...
(Date:4/27/2015)... Apr. 27, 2015 Profile Solutions, Inc. (OTC: ... security systems is pleased to announce that Dr ... consultant and member of its scientific advisory board. ... as a thought leader in technology-enhanced learning models. He ... and has published studies and books focused on online ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 2Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 3Profile Solutions Names Medicinal Cannabis, Agriculture and Technology Expert Dr. Gerry Bedore to its Scientific Advisory Board 4
... BOSTON January 31, 2013 Joslin scientists report the ... with an uncommon form of diabetes, maturity onset diabetes of ... studying the role of genetic factors in the development of ... Journal of Biological Chemistry . Human induced pluripotent ...
... They often perform vital functions. In order to become ... of proteins leads to diseases such as Alzheimer,s or ... course of evolution to improve protein folding?, To examine ... for Theoretical Studies) looked far back into the history ...
... of older people: majority of deaths from the ... (2005) occurred among older people., Researchers at the ... and Simon Fraser University,s Gerontology Research Centre in ... makers and the public of the impact climate ...
Cached Biology News:Joslin scientists find first human iPSC from patients with maturity onset diabetes of the young 2Protein origami: Quick folders are the best 2Protein origami: Quick folders are the best 3New study highlights impact of environmental change on older people 2New study highlights impact of environmental change on older people 3
(Date:5/29/2015)...  Caris Life Sciences® today announced the presentation ... utilized Caris Molecular Intelligence®, the company,s panomic, comprehensive ... in patients with colorectal and pancreatic cancer subtypes, ... protein 1 (PD-1) and its ligand, PD-L1. The ... American Society of Clinical Oncology Annual Meeting (ASCO) ...
(Date:5/29/2015)... Seoul Semiconductor (CEO: Chung-hoon Lee, ... May 28th announced that it will increase the ... high efficient and high reliable LED product line-up ... Semiconductor has developed efficient and reliable LED packages ... LEDs for headlamps to global auto makers. Seoul ...
(Date:5/28/2015)... 2015 Research ... the addition of Jain PharmaBiotech,s new ... and Companies"  to their offering.  ,     ... and evaluates animal biotechnology and its ... as well as improvement in food ...
(Date:5/28/2015)... The Academy of Model Aeronautics Foundation will be ... 15, 2015. National Model Aviation Day was created to celebrate ... flying to the general public. , The AMA has encouraged ... the celebration by hosting events in their own communities. More ... Day events. View our online event map to find ...
Breaking Biology Technology:Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 2Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 3Multi-Platform Molecular Profiling from Caris Life Sciences Identifies Clinically Actionable Targets for Novel Immunotherapy Drugs 4Seoul Semiconductor Increases the Global Automotive LED Market Share with its High Efficient and Reliable LEDs for Automotive Lightings 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 2Global Animal Biotechnology Report 2015 - Technologies, Markets and Companies Analysis to 2024 3Model flying pilots celebrate the Academy of Model Aeronautics Foundation’s Third Annual National Model Aviation Day 2
... newsletter hit a nerve as sharply as social networking has. In ... than I seem to receive on all other topics combined. (Something ... little lonely in my office.) , ,Last week, I wrote that ... , ,I said, "The value is in actively working the network ...
... campus, professors work to impart the theory and the ... for many professions, skill with information technology is key ... the School of Library and Information Studies (SLIS) at ... SLIS train students to organize and manage information. Theoretically, ...
... Corporation and EraGen Biosciences , two ... Wednesday allowing Promega to develop products using EraGens ... distribution rights for research assays. , ,Promega ... our recent SARS detection system. A market presence ...
Cached Biology Technology:Social networks: Readers respond 2Social networks: Readers respond 3Social networks: Readers respond 4Closing the IT gap 2
C/EBPalpha Antibody Shipping Temperature: Cold Storage Temperature: -20C...
...
AADAC Immunogen: AADAC (NP_001077, 201 a.a. ~ 301 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
WTAP Antibody...
Biology Products: